In its letter to the prime minister, the Swadeshi Jagran Manch has also said that drug prices regulator National Pharmaceutical Pricing Authority (NPPA) is reviewing its decision to cap the prices of stents.
Foreign companies and their industry associations have ramped up their lobbying to undermine price control and demand high prices for their stents in the name of incremental innovation, SJM co-convener Ashwani Mahajan said in the letter.
"Therefore, we request you, to uphold the right to health of Indian people and instruct NPPA not to succumb to the pressure from the foreign stent manufacturers," Mahajan said.
The letter also talks about hospital overcharging patients.
Although the decision to cap prices of stents has increased access in the one year since its implementation, many large hospitals have increased charges for angioplasty and other costs of ancillary medical devices involved in the procedure, it said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
